BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18362894)

  • 1. Photodynamic therapy: novel third-generation photosensitizers one step closer?
    Josefsen LB; Boyle RW
    Br J Pharmacol; 2008 May; 154(1):1-3. PubMed ID: 18362894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic activity of BAM-SiPc, an unsymmetrical bisamino silicon(IV) phthalocyanine, in tumour-bearing nude mice.
    Leung SC; Lo PC; Ng DK; Liu WK; Fung KP; Fong WP
    Br J Pharmacol; 2008 May; 154(1):4-12. PubMed ID: 18332853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy.
    Chen C; Wang J; Li X; Liu X; Han X
    Comb Chem High Throughput Screen; 2017; 20(5):414-422. PubMed ID: 28088891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAM-SiPc, a novel agent for photodynamic therapy, induces apoptosis in human hepatocarcinoma HepG2 cells by a direct mitochondrial action.
    Lai JC; Lo PC; Ng DK; Ko WH; Leung SC; Fung KP; Fong WP
    Cancer Biol Ther; 2006 Apr; 5(4):413-8. PubMed ID: 16481739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic necroptosis in the anti-tumor photodynamic action of BAM-SiPc, a silicon(IV) phthalocyanine-based photosensitizer.
    Zhang Y; Cheung YK; Ng DKP; Fong WP
    Cancer Immunol Immunother; 2021 Feb; 70(2):485-495. PubMed ID: 32839829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy.
    Jori G
    J Photochem Photobiol B; 1996 Nov; 36(2):87-93. PubMed ID: 9002244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Photodynamic therapy: search for ideal photosensitizer].
    Kudinova NV; Berezov TT
    Biomed Khim; 2009; 55(5):558-69. PubMed ID: 20017389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy.
    Nyman ES; Hynninen PH
    J Photochem Photobiol B; 2004 Jan; 73(1-2):1-28. PubMed ID: 14732247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy.
    O'Connor AE; Gallagher WM; Byrne AT
    Photochem Photobiol; 2009; 85(5):1053-74. PubMed ID: 19682322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photosensitizers for photodynamic therapy of cutaneous disease.
    Stapleton M; Rhodes LE
    J Dermatolog Treat; 2003 Jun; 14(2):107-12. PubMed ID: 12775318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly efficient, conjugated-polymer-based nano-photosensitizers for selectively targeted two-photon photodynamic therapy and imaging of cancer cells.
    Shen X; Li S; Li L; Yao SQ; Xu QH
    Chemistry; 2015 Jan; 21(5):2214-21. PubMed ID: 25469739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemiluminescence in Combination with Organic Photosensitizers: Beyond the Light Penetration Depth Limit of Photodynamic Therapy.
    Gao J; Chen Z; Li X; Yang M; Lv J; Li H; Yuan Z
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photosynthetic Tumor Oxygenation by Photosensitizer-Containing Cyanobacteria for Enhanced Photodynamic Therapy.
    Huo M; Wang L; Zhang L; Wei C; Chen Y; Shi J
    Angew Chem Int Ed Engl; 2020 Jan; 59(5):1906-1913. PubMed ID: 31721383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy of eye diseases.
    Rivellese MJ; Baumal CR
    Ophthalmic Surg Lasers; 1999; 30(8):653-61. PubMed ID: 10507568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.
    Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T
    Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments.
    Garland MJ; Cassidy CM; Woolfson D; Donnelly RF
    Future Med Chem; 2009 Jul; 1(4):667-91. PubMed ID: 21426032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Photodynamic therapy and urothelial carcinoma].
    Colin P; Estevez JP; Betrouni N; Nevoux P; Puech P; Leroy X; Biserte J; Villers A; Mordon S
    Bull Cancer; 2011 Jul; 98(7):769-78. PubMed ID: 21708516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy.
    Ma Z; Hu P; Guo C; Wang D; Zhang X; Chen M; Wang Q; Sun M; Zeng P; Lu F; Sun L; She L; Zhang H; Yao J; Yang F
    Int J Nanomedicine; 2019; 14():5527-5540. PubMed ID: 31413561
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of the Therapeutic Potential of Nanobody-Targeted Photodynamic Therapy in an Orthotopic Head and Neck Cancer Model.
    van Driel PBAA; Keereweer S; Lowik CWGM; Oliveira S
    Methods Mol Biol; 2022; 2451():521-531. PubMed ID: 35505029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel 3
    Zhang XJ; Han GY; Guo CY; Ma ZQ; Lin MY; Wang Y; Miao ZY; Zhang WN; Sheng CQ; Yao JZ
    Eur J Med Chem; 2020 Dec; 207():112715. PubMed ID: 32846322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.